We are live on ! Find out more
FLNA

Filana Therapeutics
FLNA

28 hedge funds and large institutions have $9.65M invested in Filana Therapeutics in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

0.74% less ownership

Funds ownership: 36.68% → 35.94% (-0.74%)

3% less capital invested

Capital invested by funds: $9.91M → $9.65M (-$261K)

15% less funds holding

Funds holding: 33 → 28 (-5)

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

Holders
28
Holders Change
-5
Holders Change %
-15.15%
% of All Funds
0.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
8
Reduced
8
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$49.7K
2
PAM
Panagora Asset Management
Massachusetts
+$31.4K
3
GI
GAMCO Investors
Connecticut
+$25K
4
Northern Trust
Northern Trust
Illinois
+$2.86K
5
BlackRock
BlackRock
New York
+$1.43K

Top Sellers

Rank Fund Capital Flow
1
GF
Gabelli Funds
New York
-$98K
2
ARTA
A.R.T. Advisors
New York
-$50.6K
3
TSS
Two Sigma Securities
New York
-$44K
4
First Eagle Investment Management
First Eagle Investment Management
New York
-$25.5K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$14.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
First Eagle Investment Management
1
First Eagle Investment Management
New York
$3.81M -$25.5K -7,143 -0.8%
NCM
2
Nantahala Capital Management
Connecticut
$1.41M +$11 +3 +0%
BI
3
BVF Inc
California
$1.32M – – –
BlackRock
4
BlackRock
New York
$756K +$1.43K +400 +0.2%
Vanguard Group
5
Vanguard Group
Pennsylvania
$748K -$14.9K -4,167 -2%
Renaissance Technologies
6
Renaissance Technologies
New York
$320K +$49.7K +13,900 +22%
Dimensional Fund Advisors
7
Dimensional Fund Advisors
Texas
$244K – – –
BCM
8
Bridgeway Capital Management
Texas
$199K – – –
Bank of New York Mellon
9
Bank of New York Mellon
New York
$171K -$350 -98 -0.2%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$114K – – –
PAM
11
Panagora Asset Management
Massachusetts
$83K +$31.4K +8,792 +75%
GI
12
GAMCO Investors
Connecticut
$81K +$25K +7,000 +54%
D.E. Shaw & Co
13
D.E. Shaw & Co
New York
$76K – – –
GS
14
Gagnon Securities
New York
$63K – – –
Northern Trust
15
Northern Trust
Illinois
$59K +$2.86K +800 +6%
California Public Employees Retirement System
16
California Public Employees Retirement System
California
$58K – – –
Susquehanna International Group
17
Susquehanna International Group
Pennsylvania
$49K +$379 +106 +0.9%
ARTA
18
A.R.T. Advisors
New York
$43K -$50.6K -14,159 -57%
Bank of America
19
Bank of America
North Carolina
$16K – – –
Group One Trading
20
Group One Trading
Illinois
$10K – – –
Wells Fargo
21
Wells Fargo
California
$6K -$1.38K -386 -23%
FANJ
22
Financial Architects (New Jersey)
New Jersey
$3K – – –
AG
23
Advisor Group
Arizona
$2K +$1.33K +371 +139%
UBS Group
24
UBS Group
Switzerland
$1K -$12.8K -3,574 -94%
Morgan Stanley
25
Morgan Stanley
New York
$1K -$1.09K -304 -45%
1
2

FLNA Hedge Fund Activity: Q3 2017 in Review

28 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q3 2017, worth a combined $9.65M — down 2.6% from $9.91M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of FLNA and 1 opened new positions — a net loss of 4 holders — while 8 trimmed existing stakes and 8 added.

The largest buyer was Renaissance Technologies, adding an estimated $49.7K. The largest seller was Gabelli Funds, exiting entirely with an estimated $98K sold.

  • 28 institutional investors held Filana Therapeutics (FLNA) as of Q3 2017, down from 33 in Q2 2017.
  • Funds reported $9.65M of Filana Therapeutics stock for Q3 2017, down 2.6% quarter-over-quarter.
  • 1 fund opened new Filana Therapeutics positions in Q3 2017 and 5 closed out, a net change of -4 holders.
  • The largest Filana Therapeutics buyer in Q3 2017 was Renaissance Technologies, an estimated $49.7K added.
  • The largest Filana Therapeutics seller in Q3 2017 was Gabelli Funds, an estimated $98K sold.

Based on aggregated 13F filings for Q3 2017.